124 related articles for article (PubMed ID: 8845926)
1. The cellular and molecular biology of medulloblastoma.
Peringa J; Fung KM; Muragaki Y; Trojanowski JQ
Curr Opin Neurol; 1995 Dec; 8(6):437-40. PubMed ID: 8845926
[TBL] [Abstract][Full Text] [Related]
2. Molecular cytogenetic analysis of medulloblastomas and supratentorial primitive neuroectodermal tumors by using conventional banding, comparative genomic hybridization, and spectral karyotyping.
Bayani J; Zielenska M; Marrano P; Kwan Ng Y; Taylor MD; Jay V; Rutka JT; Squire JA
J Neurosurg; 2000 Sep; 93(3):437-48. PubMed ID: 10969942
[TBL] [Abstract][Full Text] [Related]
3. In vivo and in vitro models of medulloblastomas and other primitive neuroectodermal brain tumors of childhood.
Trojanowski JQ; Fung KM; Rorke LB; Tohyama T; Yachnis AT; Lee VM
Mol Chem Neuropathol; 1994; 21(2-3):219-39. PubMed ID: 8086035
[TBL] [Abstract][Full Text] [Related]
4. Molecular heterogeneity in medulloblastoma with implications for differing tumor biology.
Adesina AM
J Child Neurol; 1999 Jul; 14(7):411-7. PubMed ID: 10573461
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of somatostatin receptors, P44/42 MAPK, and mTOR activation in medulloblastomas and primitive neuroectodermal tumors.
Johnson MD; O'Connell MJ; Silberstein H; Korones D
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):532-8. PubMed ID: 23455179
[TBL] [Abstract][Full Text] [Related]
6. Neurotrophin and neurotrophin receptor proteins in medulloblastomas and other primitive neuroectodermal tumors of the pediatric central nervous system.
Washiyama K; Muragaki Y; Rorke LB; Lee VM; Feinstein SC; Radeke MJ; Blumberg D; Kaplan DR; Trojanowski JQ
Am J Pathol; 1996 Mar; 148(3):929-40. PubMed ID: 8774147
[TBL] [Abstract][Full Text] [Related]
7. Genetic alterations in glioma and medulloblastoma.
Rasheed BK; Bigner SH
Cancer Metastasis Rev; 1991 Dec; 10(4):289-99. PubMed ID: 1786630
[TBL] [Abstract][Full Text] [Related]
8. Expression of neurogenic basic helix-loop-helix genes in primitive neuroectodermal tumors.
Rostomily RC; Bermingham-McDonogh O; Berger MS; Tapscott SJ; Reh TA; Olson JM
Cancer Res; 1997 Aug; 57(16):3526-31. PubMed ID: 9270024
[TBL] [Abstract][Full Text] [Related]
9. PTEN and DMBT1 homozygous deletion and expression in medulloblastomas and supratentorial primitive neuroectodermal tumors.
Inda MM; Mercapide J; Muñoz J; Coullin P; Danglot G; Tuñon T; Martínez-Peñuela JM; Rivera JM; Burgos JJ; Bernheim A; Castresana JS
Oncol Rep; 2004 Dec; 12(6):1341-7. PubMed ID: 15547761
[TBL] [Abstract][Full Text] [Related]
10. [Hypermethylation as a potential prognostic factor and a clue to a better understanding of the molecular pathogenesis of medulloblastoma--results of a genomewide methylation scan].
Frühwald MC; O'Dorisio MS; Smith L; Dai Z; Wright FA; Paulus W; Jürgens H; Plass C
Klin Padiatr; 2001; 213(4):197-203. PubMed ID: 11528554
[TBL] [Abstract][Full Text] [Related]
11. Animal models of medulloblastomas and related primitive neuroectodermal tumors. A review.
Fung KM; Trojanowski JQ
J Neuropathol Exp Neurol; 1995 May; 54(3):285-96. PubMed ID: 7745427
[TBL] [Abstract][Full Text] [Related]
12. Molecular diagnostics in embryonal brain tumors.
Eberhart CG
Brain Pathol; 2011 Jan; 21(1):96-104. PubMed ID: 21129063
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of SOX2, NOTCH1, and ID1 in supratentorial primitive neuroectodermal tumors: a distinct differentiation pattern from that of medulloblastomas.
Phi JH; Kim JH; Eun KM; Wang KC; Park KH; Choi SA; Kim YY; Park SH; Cho BK; Kim SK
J Neurosurg Pediatr; 2010 Jun; 5(6):608-14. PubMed ID: 20515335
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of chromosome 17p deletions in childhood primitive neuroectodermal tumors (medulloblastomas) of the central nervous system.
Biegel JA; Janss AJ; Raffel C; Sutton L; Rorke LB; Harper JM; Phillips PC
Clin Cancer Res; 1997 Mar; 3(3):473-8. PubMed ID: 9815707
[TBL] [Abstract][Full Text] [Related]
15. Immunocytochemical detection of the homeobox B3, B4, and C6 gene products in childhood medulloblastomas/primitive neuroectodermal tumors.
Bodey B; Bodey B; Siegel SE; Kaiser HE
Anticancer Res; 2000; 20(3A):1769-80. PubMed ID: 10928106
[TBL] [Abstract][Full Text] [Related]
16. Neurotrophins and neuronal versus glial differentiation in medulloblastomas and other pediatric brain tumors.
Tajima Y; Molina RP; Rorke LB; Kaplan DR; Radeke M; Feinstein SC; Lee VM; Trojanowski JQ
Acta Neuropathol; 1998 Apr; 95(4):325-32. PubMed ID: 9560008
[TBL] [Abstract][Full Text] [Related]
17. Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review.
Taylor MD; Mainprize TG; Rutka JT
Neurosurgery; 2000 Oct; 47(4):888-901. PubMed ID: 11014429
[TBL] [Abstract][Full Text] [Related]
18. Chromosome arm 17p deletion analysis reveals molecular genetic heterogeneity in supratentorial and infratentorial primitive neuroectodermal tumors of the central nervous system.
Burnett ME; White EC; Sih S; von Haken MS; Cogen PH
Cancer Genet Cytogenet; 1997 Aug; 97(1):25-31. PubMed ID: 9242214
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional profiling of medulloblastoma in children.
Park PC; Taylor MD; Mainprize TG; Becker LE; Ho M; Dura WT; Squire J; Rutka JT
J Neurosurg; 2003 Sep; 99(3):534-41. PubMed ID: 12959442
[TBL] [Abstract][Full Text] [Related]
20. Medulloblastomas: do molecular and biologic markers indicate different prognoses and treatments?
Brandes AA; Paris MK; Basso U
Expert Rev Anticancer Ther; 2003 Oct; 3(5):615-20. PubMed ID: 14599085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
